Liquidia Corporation Share Price

Liquidia Corporation Share Price

NASDAQ: LQDA | Mid Cap
$45.03
-$0.67 (-1.47%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Liquidia Corporation Stock Performance

Open
$46.12
Prev. Close
$45.70
Circuit Range
N/A
Day Range
$44.46 - $47.04
Year Range
$22.08 - $93.50
Volume
1,27,341
Average Traded
$45.54

Liquidia Corporation Share Price Today

As of 30 October 2026, Liquidia Corporation's share price is $45.03. The stock opened at $46.12, compared to its previous close of $45.70. During today's trading session, Liquidia Corporation's share price traded between $44.46 and $47.04, with an average price of $45.75. Over the past 52 weeks, the stock has recorded a high of $93.50 and a low of $22.08. In terms of performance, Liquidia Corporation's share price has risen by 14.78% over the last six months and is up 84.85% on a year-on-year basis.

Liquidia Corporation Share Price Chart

Line chart of the Liquidia Corporation price trend over the selected period. The price fell overall, ranging from 44.49 to 47.04, ending at 45.03.
$44.46$47.04
L
Show Current Price
H

Liquidia Corporation Stock Fundamentals & Key Indicators

Market Cap
$3.88B
PE Ratio (TTM)
29.53
Dividend Yield
0.00%
EPS (TTM)
$1.55
Revenue (TTM)
$158.32B
Return On Equity (TTM)
71.04%
Profit Margin
-43.53%
Debt to Equity
0.90
Quarterly Earnings Growth YoY
2216.71%

Liquidia Corporation Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$54.34$92.02$132.87$171.68
Net Profit-$3.53$14.56$52.86$74.72
Net Profit Margin-6.50%15.82%39.78%43.52%
Income ChangeN/A512.46%263.05%41.35%

Liquidia Corporation Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$15.94$17.49$14.00$158.32
Net Profit-$41.02-$78.50-$128.29-$68.92
Net Profit Margin-257.34%-448.83%-916.36%-43.53%
Income ChangeN/A-91.37%-63.43%46.28%

About Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Liquidia Corporation Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$24.02
$45.00
+48.51%
Sep 2026
$68.31
$30.30
-56.68%
Aug 2026
$80.70
$69.95
-16.82%
Jul 2026
$78.77
$84.09
+5.43%
Jun 2026
$60.30
$79.76
+28.95%
May 2026
$38.95
$61.85
+57.67%
Apr 2026
$37.91
$39.23
+4.03%
Mar 2026
$30.72
$37.71
+21.57%
Feb 2026
$43.17
$31.02
-26.87%
Jan 2026
$34.66
$42.42
+22.89%
Dec 2025
$32.13
$34.52
+5.81%
Nov 2025
$27.04
$32.63
+33.93%

LQDA Share Price FAQs